CareDx, Inc. CDNA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.29% | 52.23% | 38.99% | 25.19% | 20.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.29% | 52.23% | 38.99% | 25.19% | 20.72% |
| Cost of Revenue | 31.42% | 22.01% | 18.35% | 25.97% | 11.18% |
| Gross Profit | 42.76% | 67.15% | 49.41% | 24.81% | 25.47% |
| SG&A Expenses | 24.70% | 43.08% | 32.99% | 11.02% | 2.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.17% | 35.14% | 25.03% | 16.17% | 3.83% |
| Operating Income | 4,901.63% | 102.39% | 122.44% | 49.33% | 98.21% |
| Income Before Tax | 544.10% | 1,418.57% | 126.97% | -104.28% | 115.90% |
| Income Tax Expenses | -57,233.33% | 3,417.95% | -155.17% | 101.75% | -107.50% |
| Earnings from Continuing Operations | 1,051.76% | 1,391.27% | 127.13% | -104.68% | 115.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,051.76% | 1,391.27% | 127.13% | -104.68% | 115.75% |
| EBIT | 4,901.63% | 102.39% | 122.44% | 49.33% | 98.21% |
| EBITDA | 432.96% | 143.52% | 229.07% | 74.79% | 134.80% |
| EPS Basic | 1,060.50% | 1,462.23% | 129.31% | -104.98% | 115.86% |
| Normalized Basic EPS | 771.72% | 119.60% | 174.01% | 66.18% | 116.06% |
| EPS Diluted | 1,066.67% | 1,393.75% | 126.32% | -105.34% | 114.92% |
| Normalized Diluted EPS | 726.26% | 119.60% | 171.15% | 63.72% | 116.06% |
| Average Basic Shares Outstanding | -0.75% | -5.22% | -7.44% | -5.82% | -0.75% |
| Average Diluted Shares Outstanding | 4.72% | -5.22% | -3.86% | -12.19% | -0.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |